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Abstract
Background: There is growing recognition that the wider benefits of research (economic, social and health
impacts) should be assessed and valued alongside traditional research performance metrics such as peer-reviewed
papers. Translation of findings into policy and practice needs to accelerate and pathways to impact need to be better
understood. This research protocol outlines a mixed methods study to apply the Framework to Assess the Impact from
Translational health research (FAIT) to the Centre for Research Excellence in Stroke Rehabilitation and Brain Recovery
(CRE-Stroke). FAIT is purpose-designed to encourage research translation and assess research impact but lacks
validation.
Methods/Design: Phase 1 involves application of the FAIT-modified programme logic model to each CRE-
Stroke research stream including identifying process, output and impact metrics, as well as end users of the
research. A scoping review will inform potential impacts anticipated from CRE-Stroke. In Phase 2, audit and
feedback on achievements against plans will track and encourage research translation. Logic models will be
updated to account for changes in the research pathways over time. In Phase 3, three proven methods for
measuring research impact – Payback, economic assessment and narratives – will be applied to each research
stream and the data triangulated and reported in Phase 4. The feasibility of applying FAIT will also be assessed as part
of Phase 3.
Discussion: Use of prospective, comprehensive research impact frameworks for large interdisciplinary programmes of
research is rare. FAIT’s application to CRE-Stroke will provide opportunity for the impact of CRE-Stroke to be assessed
and a range of impacts beyond standard academic achievements to be reliably reported. The feasibility of FAIT’s
application will also be assessed and, if necessary, refined. The usefulness of FAIT for encouraging research
translation will also be described and may prove useful for other programmes looking to implement a research impact
framework.
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Background
Stroke is a leading cause of death and disability around
the world [1]. In Australia, stroke is the leading cause of
disability, with over 50,000 stroke cases annually, and
the second largest cause of death [2]. In 2012, there were
over 420,000 stroke survivors in Australia living with the
effects of stroke [3]. The total financial cost of stroke in
Australia was estimated to be close to AUD 5 billion in
2012. However, the biggest impact of stroke is the loss
of healthy life. Using the market-based price of risk
methodology required by the Commonwealth Depart-
ment of Finance and Deregulation, the total burden of
disease cost for stroke in 2012 was AUD 49.3 billion [4].
In recent decades, there have been important advances
in the field of stroke with the emergence of strong evi-
dence for approaches to stroke recovery [5]. Neverthe-
less, there have been significant delays in implementing
evidence into clinical practice [6, 7] and stroke survivors
often do not receive care based on the best available evi-
dence. For example, in Australia, one in five stroke sur-
vivors are still discharged without a care plan and only
half are assessed for mental wellbeing [8, 9].
Recognising a need to expand the evidence base for re-
habilitation interventions, improve recovery from stroke
and reduce the burden of disease cost for stroke, the Na-
tional Health and Medical Research Council (NHMRC)
of Australia funded the Centre for Research Excellence
in Stroke Rehabilitation and Brain Recovery (CRE-S-
troke). The vision for CRE-Stroke is to transform the
stroke rehabilitation research and practice landscape in
Australia and accelerate the development, translation
and implementation of new interventions that are
strongly supported by neuroscience [10].
The NHMRC Centre for Research Excellence scheme
provides support for teams of researchers to pursue col-
laborative research and develop capacity in clinical,
population health or health services research. A major
objective of the CRE-Stroke research programme is to
use an impact framework to encourage research transla-
tion and assess the impact of its five research streams
(Basic Science, Clinical Trials, Neuroimaging, Imple-
mentation and Data Linkage). This is because a substan-
tial amount of health and medical research fails to be
fully translated and is therefore not taken advantage of
by end users for policy and practice, thus limiting impact
[11]. There is also a growing demand for more account-
ability in public spending across all sectors, including
health [12]. Any level of suboptimal translation means
the potential rates of return from research investments
may not be realised. In this protocol, we define ‘research
translation’ as “the process of knowledge generation and
transfer that enables those utilising the developed know-
ledge to implement it” [13]. The definition for ‘research
impact’ modified for the health and medical research
context is “the demonstrable effect from basic, health sys-
tems, patient and population-orientated research, and
clinical trials, that ultimately improves healthcare deliv-
ery, human health and quality of life, and generates ben-
efits for the economy, society, culture, public policy, or the
environment” [14].
There is growing recognition that translation of re-
search into policy and practice needs to increase and
that the pathways to realising impact need to be more
transparent [15]. Moreover, impact assessment beyond
academic outputs such as peer-reviewed publication ci-
tations is still not standard practice in many countries
[16]. One exception is the United Kingdom, which is
leading the way in implementing an impact assessment
agenda and, for the first time in 2014, included impact
assessment in the national Research Excellence Frame-
work [17]. There is a plethora of impact assessment
frameworks available, including two recent systematic
reviews of these frameworks, models and applications
[18–20]. However, there is a lack of evidence to suggest
that the availability of these frameworks and models has
increased the proportion of health and medical research
projects that assess and report on broad concepts of im-
pact beyond the narrow scope of academic outputs.
There have been several studies trialling the use of
impact assessment applications in Australia, but a na-
tional framework for assessment of research impact has
not yet been implemented. However, there have been
major national developments in this field, including (1)
the Excellence in Research for Australia National
framework [21], (2) NHMRC’s Advanced Health
Research and Translation Centres Program and Centres
for Innovation in Regional Health [22], (3) the Medical
Research Future Fund [23], and (4) Australian Research
Council’s national engagement and impact assessment
framework [24, 25]. These initiatives confirm that
research translation and impact assessment are
currently high on Australia’s research agenda. Attempts
to close the gap between research outputs and impacts
are strongly encouraged and likely to remain policy
relevant.
Recently, the Australian Commission on Safety and Qual-
ity in Healthcare released a report quantifying the overall
health and economic impact of 25 investigator-initiated
clinical trials conducted by three select clinical trials net-
works, including the Australasian Stroke Trials Network
[26]. The report was able to demonstrate that increasing
implementation of trial evidence into practice can lead to
considerable additional health and economic gains. It
showed that the results of these 25 trials only needed to be
implemented in 11% of eligible populations for benefits to
outweigh costs. This is one of the first reports in Australia
to quantify impact from clinical trials and further similar
studies are warranted.
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The impact assessment framework selected to guide
the review of CRE-Stroke is the Framework to Assess
the Impact from Translational health research (FAIT),
developed by a team of health economists and health
and medical researchers based at the Hunter Medical
Research Institute with the specific aim of encouraging
and measuring research translation and impact. Details
of the framework have been previously published and
provide a comprehensive account of the development of
FAIT and the components of the framework [27]. Briefly,
the framework was based on a mixed methods study in-
volving (1) a scoping review of existing research impact
frameworks and techniques to inform the development
of FAIT, (2) a development stage to design the prototype
and (3) a feedback stage where iterations of the proto-
type were presented to researchers for discussion and re-
finement. FAIT is based on a modified programme logic
model and a hybrid of three proven methodologies for
measuring research impact; namely quantified metrics,
economic analysis and narratives of the process by
which research translates and generates impact. The
adoption of FAIT by CRE-Stroke presents an opportun-
ity to pilot the framework’s application and test the feasi-
bility of its research translation capability. It also allows
its impact assessment methodology to be applied to
‘streams of research’ rather than specific research pro-
jects. This paper describes the protocol of a mixed
methods study to document the pathway to translation
and assess the impact of five streams of stroke rehabili-
tation research associated with CRE-Stroke.
Methods/design
This study involves the application of a research impact
framework (FAIT) to encourage research translation and
assess research impact [27]. The aims are to:
1. Provide transparency to the pathway to generating
research impact
2. Test the utilisation of impact assessment to
encourage greater research translation
3. Assess the impact of the five research streams of
CRE-Stroke
4. Test the feasibility of using FAIT’s package of
validated impact assessment methodologies on an
interdisciplinary research programme in stroke
5. Build the knowledge and capability within the CRE-
Stroke research team regarding research translation
and impact assessment
The anticipated outcomes will be greater translation of
research within CRE-Stroke and an evidence-based report
of the impact of CRE-Stroke. The setting will be
CRE-Stroke, which brings together an interdisciplinary
team of internationally recognised and aspiring researchers
primarily from the two major stroke research centres
in Australia, namely the Florey Institute of Neurosci-
ence and Mental Health in Melbourne, Victoria, and
Hunter Medical Research Institute in Newcastle,
New South Wales. Associate researchers and
affiliates are based at other sites in Australia. This
collaborative effort, with close to 300 network
members, is worth AUD 2.5 million over 5 years and
unifies stroke researchers from basic science,
rehabilitation, health services research and imple-
mentation science and provides opportunities for
collaboration with clinicians, policy-makers, industry,
consumers and carers.
Participants for this study will be a mix of experienced,
early career and student researchers associated with all
research streams within CRE-Stroke and stakeholders
such as clinicians, policy-makers, representatives of con-
sumer organisations, advocates, and stroke carers and
survivors.
The framework will be applied to all five research streams
of CRE-Stroke (described in Table 1). The aims are to pro-
vide transparency to the translation process, increase cap-
acity to improve the speed of translation (when applied
prospectively) and, ultimately, to promote a systematic as-
sessment of the impact of these research streams.
The study design involves a four-stage sequential
mixed method design, summarised as follows:
Phase 1: Develop a modified programme logic model
for each of CRE-Stroke’s five research streams. A
scoping review will be used to identify potential
benefits from the work of CRE-Stroke and values
or sources of value associated with those benefits.
Phase 2: The implementation of FAIT focusing on data
collection of evidence to indicate the achievement
of process, outcome and impact metrics. This phase
will also incorporate a process evaluation to collect
participants’ perceptions of FAIT and its implementation.
Phase 3: The package of FAIT methodologies
for impact assessment, namely quantified metrics
[28], economic assessment and narratives, will be
used to assess the impact of the five research
streams.
Phase 4: The results will be summarised and presented
by way of scorecards, including narratives describing
the process by which the CRE-Stroke research translated
and generated impact. The outcomes of both the
implementation of FAIT and the results of the impact
assessment of the five research streams will be compiled
and disseminated.
The following sections provide details about the
methods for each of the four phases of the study, which
may overlap slightly in practice.
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Phase 1
Modified programme logic models
“A logic model is a systematic and visual way to
present and share your understanding of the relation-
ships among the resources you have to operate your
program, the activities you plan, and the changes or re-
sults you hope to achieve” [29]. A modified programme
logic model underpins all the three FAIT impact as-
sessment methods. There are two modifications for
FAIT – the main modification relates to the insertion
of ‘end users’, with the advantage of identifying who
will use the research outputs for impact assessment
purposes. In the context of FAIT, end users are de-
fined as collaborators along the pathway to impact
that are co-creators and/or co-users of the research
outputs [27]. Within CRE-Stroke, this includes clini-
cians, rehabilitation providers, consumer representa-
tives, industry partners, stroke survivors and carers.
Another modification is the introduction of process
and output metrics in addition to impact metrics to
provide greater transparency between the aims and
intended impacts of the research. Process metrics help
identify when key activities of the research have oc-
curred. Output metrics help identify when key outputs
or products of the research have been produced. Im-
pact metrics reflect the consequence of the research
output being used by end users.
The purpose of the logic models within CRE-Stroke
will be to provide strategic maps of how each of the
five research streams plans to generate impact and
link the aims of each stream to the research activities.
These activities should produce an output that, when
utilised by an end user, creates an opportunity for the
generation of impact. While recognising that transla-
tion is a multidirectional phenomenon, this approach
provides ‘line of sight’ from need to research to im-
pact, outlined in Fig. 1.
The value in articulating these processes in a
programme logic model is to give transparency to
how researchers anticipate their project will generate
impact, including any interim impacts. It also pro-
vides an opportunity to include activities that have (in
the literature) been associated with successful transla-
tion and the generation of impact such as engage-
ment with end users upfront [30]. Further, logic
models also provide a framework for the development
of metrics and the collection of evidence of achieve-
ment of translational activities and impact.
Five modified programme logic models have been de-
veloped collaboratively with CRE-Stroke researchers dur-
ing a planning workshop for CRE-Stroke. While
programme logic models appear linear within Fig. 1 (ne-
cessary for the development of a logic model) their ap-
plication, including project development and refinement,
Table 1 Centre for Research Excellence in Stroke Rehabilitation and Brain Recovery (CRE-Stroke) research streams used for
implementation of the Framework to Assess the Impact of Translational health research (FAIT)
Research stream Synopsis
Basic science Persistent psychological distress and fatigue are common problems affecting stroke survivor rehabilitation. These problems are
under-researched because they are difficult to assess with existing techniques. The Basic Science workstream will address this
need through two basic science projects – the first will assess chronic stress in recovering stroke survivors through the measurement
of hair cortisol. The second will explore the relationship between inflammation and post-stroke recovery.
Neuroimaging This workstream addresses two broad themes, namely (1) early (post-stroke) neuroimaging to predict stroke recovery and
develop neuroimaging and clinical profiles to inform potential for recovery and allow better stratification of stroke patients in
clinical trials, and (2) serial neuroimaging as a biological marker of stroke recovery and ability to benefit from rehabilitation and
to inform targeted approaches to rehabilitation interventions. The aim is to learn the characteristics of brain function, structure
and metabolism associated with recovery and rehabilitation in those who recover well. This will help inform individual tailoring
of rehabilitation interventional approaches.
Clinical trials This workstream will facilitate the following outcomes with regard to clinical trials in stroke rehabilitation science: improved
quality, greater standardisation and increased trial size. Specifically, the workstream will:
(1) Develop a platform for rehabilitation trials, with sharing of procedures and resources to increase efficiencies
(2) Develop a national training programme
(3) Pool trial data to allow novel hypotheses to be developed and improve patient stratification.
It is expected that new trials using this information will be developed.
Implementation
science
This workstream aims to maximise the translation of effective and cost-effective research from the CRE-Stroke into real-world
use and contribute new knowledge to the field of implementation science. The workstream will develop an education
programme, a research implementation template, and implementation models and strategies (products) to transfer knowledge
from researchers to end-users. This work will be underpinned by appropriate theoretical frameworks to understand the factors
that impede or enable implementation to occur at a patient, clinical and/or system level. The effectiveness of implementation
models and strategies will be measured and reported.
Data linkage This workstream will (1) work to link databases in order to better understand the full survivor journey in hospitals and show the
associations between the type and quality of care received with longer-term outcomes; (2) facilitate access to already linked
datasets held by CRE-Stroke investigators; (3) provide a high level Standard Operating Procedure to facilitate access to available
or newly established linked datasets related to stroke rehabilitation; and (4) create new knowledge through the analysis of
linked data. This workstream does not intend to be the custodian of linked datasets. However, it will provide a universal
governance process for using linked data of relevance to stroke rehabilitation.
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is, in most part, non-linear and iterative in nature.
Hence, the logic models are intended to be living docu-
ments open to change at all stages of the research pipe-
line to ensure they capture the actual translational
pathways to impact over the lifecycle of CRE-Stroke.
Scoping review
A scoping review will be used to identify indicators of
impact that will inform the benefits that may be ex-
pected from the work of CRE-Stroke, as guided by its
objectives. For example, the Becker Medical Library
Model for Assessment of Research Impact consists of a
list of indicators to document evidence of biomedical re-
search impact [31]. To avoid unnecessary duplication,
existing indicators such as these will be the starting
point for selection of impact metrics and supplemented
with more customised metrics specific to each research
stream. These existing indicators will also be used to
identify potential values or sources of value associated
with those anticipated benefits.
The review process will follow the Joanna Briggs Insti-
tute guideline for scoping reviews [32]. While still meth-
odical, scoping reviews are typically broader in their
focus with less restrictive inclusion criteria than system-
atic reviews [33]. The review will be used to map the key
concepts underpinning the assessment of impact on the
delivery of stroke rehabilitation research. As outlined in
the Joanna Briggs Institute guideline, a three-step search
strategy will be used. Provisionally, step 1 will involve
the development of a literature search strategy including
appropriate MeSH and free-text terms that can be used
to source articles from a subset of relevant databases.
CRE-Stroke researchers will be consulted during this
phase of the review. Step 2 will involve screening of the
title and abstract of any retrieved papers and of the
index terms used to describe the articles. A second
search will then be undertaken using all identified key-
words and index terms across all included databases. In
step 3, the reference list of all identified reports and arti-
cles will be hand-searched for additional studies. In this
review, literature will be drawn from both economic
(e.g. Econlit and Jstore) and general health and medical
academic databases (e.g. Medline, Embase, CINAHL,
Cochrane Database of Systematic Reviews). The
searches will also extend to Google Scholar and Goo-
gle to identify grey literature from government de-
partments, international organisations and research
funders. The searches will be limited to articles pub-
lished in English between 1995 and 2017. This time-
frame is considered appropriate because knowledge
translation, a precursor to impact assessment, gained
prominence from the late 1990s [34].
The data from the review will be charted to record
categories of impact and key benefits that may be antici-
pated from CRE-Stroke. In line with recommended
scoping review guidelines, the charting of results will be
iterative [33, 35]. No formal assessment of the quality of
the studies will be undertaken, consistent with the meth-
odology for a scoping review.
Phase 2
Monitoring, feedback and data collection for process
evaluation
Phase 2 of the study will comprise monitoring progress
of all research streams over remaining months of
CRE-Stroke operations until end December 2019. This
will entail sharing the programme logic models with all
CRE-Stroke members and affiliates, allowing for feed-
back and modifications to the five models at 6-monthly
intervals. Through a process of monitoring and feed-
back, teams from each stream will have the opportunity
to assess how they are tracking against their planned ac-
tivities, outputs and intended impacts, to provide evi-
dence of achievement of process, output and impact
goals, and to refine their research translation and en-
gagement activities to maximise impact. In addition,
CRE-Stroke members and affiliates will be exposed to
current thinking around research translation, implemen-
tation and impact through workshops, webinars and for-
ums conducted by CRE-Stroke.
Data collection for this stage of the study will also in-
volve a series of online and telephone surveys of
CRE-Stroke researchers and associates to elicit their per-
ceptions of FAIT, determine if the framework encourages
translational behaviours and how the implementation of
the framework can be improved. This is in line with a
Fig. 1 Modified programme logic model
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process evaluation of the application of FAIT. Participants
will also be asked to articulate which aspects of the frame-
work are effective and which need refinement.
Phase 3
Analysis of collected data – research impact assessment
and valuation
Currently, there is no single assessment method capable
of capturing the impacts stemming from health and
medical research. Therefore, FAIT employs a combin-
ation of three separate but integrated proven methods,
namely quantified metrics [36], economic assessment
[37] and narratives of the process by which the research
in question translates and generates impact (Fig. 2).
Using qualitative project examples, the narratives will be
triangulated against the quantified metrics and the eco-
nomic assessment to validate the impact of the research
in question.
Impact metrics for the modified Payback model
The impact metrics referred to in FAIT are a variation of
the methods used in the Payback Framework [38]. The
Payback Framework was originally developed to examine
the ‘impact’ or ‘payback’ of health services research. It
consists of a logic model representation of the complete
research process and a series of categories to classify
paybacks from research from the more traditional aca-
demic benefits of knowledge production to wider bene-
fits to society. Impact metrics will be organised under
broad domains of benefit such as impacts on knowledge,
policy, practice, economics and community. These im-
pact metrics will be structured to support the planned
economic assessment. Robust impact metrics that are
contextually relevant to stroke rehabilitation research,
such as inclusion in stroke rehabilitation guidelines or
improvement in arm function post-stroke, will be se-
lected with consideration to objectivity, administrative
efficiency, transparency and comparability, as well as
their ability to be verified. Additionally, some of these
impact metrics are more like indicators that can be evi-
denced rather than measured (e.g. inclusion in guide-
lines) and will be reported accordingly.
Economic assessment
The economic assessment will involve a comparison of
the costs associated with developing and implementing
Fig. 2 Validated impact assessment methodologies used in FAIT
Ramanathan et al. Health Research Policy and Systems  (2018) 16:71 Page 6 of 10
the five research streams versus a calculated value for
the expected impact or benefit of the funded research.
This will provide an estimate of return on investment
(ROI). The nature of some CRE-Stroke activities and
available data on costs may impact on the type of eco-
nomic assessment that is feasible and useful. The
planned assessment will collect, on a case-by-case basis,
the resources used to fund the research, including
non-CRE-Stroke funding expended on each activity. The
cost of running the CRE-Stroke programme will be ap-
propriately apportioned across the five research streams,
including any cross-cutting programmes. Additional
costs in utilising the research outputs of each stream will
also be included. For example, the development of serial
neuroimaging as a biological marker of stroke recovery
will help inform individual tailoring of rehabilitation
interventional approaches. Resources will be consumed
to develop and evaluate the protocols and information
required to conduct such imaging. Implementation of
that protocol might increase the number of imaging
tests performed on patients with stroke. These tests may
incur additional costs to the health system and their
costs will be accounted for. Implementation of that im-
aging protocol might also have positive impacts on
short- and long-term recovery from stroke, which can be
reported as downstream savings to the health system
and society.
The programme logic models will assist in articulating
programme inputs, expected outputs, uptake and ultim-
ate impact. The total calculated expected costs and ben-
efits will be combined to estimate ROI. Depending on
the focus and stage of each research stream, three broad
steps will be involved in the economic assessment,
namely (1) identification and assessment of resource use,
(2) assessment and valuation of the expected impact,
where possible, and (3) comparison of the costs and ex-
pected impacts, where possible, in a single metric.
Where practical, the analysis will assume a societal per-
spective to ensure all possible costs and benefits are
accounted for. The time horizon for the assessment will
be bounded in the base case analysis by the period dur-
ing which the programme received core funding, i.e.
2015–2019. Expected costs and impacts will be reported
in net present value terms and streams of projected fu-
ture costs and benefits will be discounted at a base case
rate of 3% [39].
Identification, assessment and valuation of resource use
Resource use associated with development and deliv-
ery of the research/interventions will be costed using fi-
nancial and administrative records from the respective
research teams. The costs associated with translation of
the project findings and outputs will include any costs
(including opportunity costs) incurred by the various
health service organisations such as costs related to
practice change. As stated above, it may be problematic
to collect data to inform these costs. However, some at-
tempt will be made to model these costs using adminis-
tration records and detailed descriptions of uptake
obtained from health services.
Assessment and valuation of the expected impact
Impact will be calculated for selected domains for
each of the five programme logic models. The calcu-
lations will be adjusted for risk to give the expected
value of the impact. Attribution will be assigned at a
conservative rate, the value of which will be informed
by administrative and evaluation records and qualified
during researcher and other interviews. Projected val-
uations will include a ‘drop-off ’ factor to account for
waning benefit over time [39]. Variation in both attri-
bution and drop off factors will be included in a
sensitivity analysis. Any and all assumptions under-
pinning the analysis will be made explicit in the
reporting of the results.
Narratives (case studies)
The FAIT approach also incorporates the use of illus-
trative examples or narratives that will be compiled
for each research stream to describe, in more qualita-
tive terms, how translation occurred and how impact
was generated for each stream [27]. The use of nar-
ratives has been the basis of the research evaluation
system currently used in the United Kingdom [40].
Narratives are useful for describing the often com-
plex pathways for research translation and can be
powerful tools for communicating the nature and ex-
tent of research translation and, ultimately, research
impact with policy-makers, funders and the wider
community. They also enable quantitative findings to
be placed in context and are an opportunity to ex-
plain variances in research costs, outputs and im-
pacts. In this application within CRE-Stroke, it is
expected that the narratives will be supported with
quantitative evidence extracted from the quantified
metrics and economic assessments and will be used
to triangulate and validate the impact findings. It is
expected that the narratives will be informed by in-
terviews with key CRE-Stroke researchers, affiliates
and key stakeholders, including end users of the re-
search such as clinicians and health service staff.
This collaborative and prospective approach to the
development of the narratives will render them less
likely to be impacted by biases such as selective
memory, which often characterise narratives based
only on self-reports [41].
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Phase 4
Reporting and recommendations around the
implementation of FAIT
Outcome 1: The results, including the narratives, will be
summarised and reported by way of a scorecard (see
Fig. 3 for a hypothetical scorecard). These scorecards
will form the basis of CRE-Stroke reporting of the trans-
lation and impact of its five research streams and poten-
tially dovetail into an overall evaluation of the CRE.
Outcome 2: The findings from the implementa-
tion of FAIT within CRE-Stroke and specifically
about its applicability to research streams, as
opposed to research projects, will be compiled. A
workshop with key CRE-Stroke researchers and
stakeholders will be conducted to discuss the
findings and obtain feedback with a view to refining
FAIT for future use.
Limitations
This study is being conducted in a real-world setting.
Impact assessments are resource intensive and, although
the prospective collection of evidence is more
cost-effective, not all the required data can be collected
prospectively. Final metrics for the Payback assessment
and data for the narratives and economic assessments
for each stream will be based on what can feasibly be
collected versus an ideal list of impact metrics. The lag
between research translation and impact means that val-
uations may need to be undertaken with reference to in-
terim rather than final impacts. For CRE-Stroke streams
Fig. 3 Hypothetical scorecard for reporting Framework to Assess the Impact of Translational health research (FAIT) impact findings
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that are more advanced, this constraint will be less prob-
lematic compared to projects that have commenced
more recently. Conduct of the study in a real-world set-
ting means there are no controls (counterfactuals or
what would have happened in the absence of
CRE-Stroke), thus attribution of impact for all five
streams will be necessarily conservative. They will also
be constrained, in some cases, by the evidence available
to substantiate claims that specific impacts are attribut-
able to the research being assessed. Finally, FAIT is pro-
ject based and is being applied to five research streams.
A limitation, therefore, is that this study will not assess
the impact of individual CRE-Stroke research projects,
including randomised controlled trials that could poten-
tially have large impacts once fully translated.
Discussion
This protocol describes a mixed methods study to apply a
systematic framework to encourage research translation
and assess impact beyond academic outputs. Academic
outputs are already well reported by Excellence in Re-
search for Australia, however, they provide an incomplete
assessment of ROI, particularly for health and medical re-
search. Most existing impact assessment frameworks are
retrospective and provide accountability for past research
investments. FAIT is prospective in design and incorpo-
rates monitoring and feedback with the explicit aim of en-
hancing translation and impact. This study will capture
processes, outputs and impacts generated across the
spectrum of stroke rehabilitation research from discovery
to applied science, utilise cost-effective data collection
techniques and facilitate a wider range of reportable out-
puts and impact of research for CRE-Stroke. It stands to
make a solid contribution to our understanding of re-
search translation and impact assessment from the per-
spective of a programme of research that encourages
interdisciplinary capacity-building.
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